Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with …
Background The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with …
SD Nathan, C Albera, WZ Bradford, U Costabel… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with …
SD Nathan, C Albera, WZ Bradford, U Costabel… - Thorax, 2016 - search.proquest.com
Background The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with …
SD Nathan, C Albera, WZ Bradford, U Costabel… - THORAX, 2016 - iris.unito.it
BACKGROUND: The assessment of treatment response in idiopathic pulmonary fibrosis
(IPF) is complicated by the variable clinical course. We examined the variability in the rate of …
(IPF) is complicated by the variable clinical course. We examined the variability in the rate of …
[PDF][PDF] Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in …
SD Nathan, C Albera, WZ Bradford, U Costabel… - 2016 - researchmgt.monash.edu
Background The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …
[PDF][PDF] Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in …
SD Nathan, C Albera, WZ Bradford, U Costabel… - 2016 - academia.edu
Background The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: Analysis of data from three phase 3 trials in patients with …
SD Nathan, C Albera, WZ Bradford, U Costabel… - thorax.bmj.com
6MWD= 6-minute walk test distance; DLCO= carbon monoxide diffusing capacity; FEV1=
forced expiratory volume in 1 second; FVC= forced vital capacity; HRCT= high resolution …
forced expiratory volume in 1 second; FVC= forced vital capacity; HRCT= high resolution …
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: Analysis of data from three phase 3 trials in patients with …
SD Nathan, C Albera, WZ Bradford, U Costabel… - Thorax, 2016 - research.monash.edu
Background: The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with …
SD Nathan, C Albera, WZ Bradford, U Costabel… - Thorax, 2016 - scholarship.miami.edu
BackgroundThe assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with …
SD Nathan, C Albera, WZ Bradford, U Costabel… - Thorax, 2016 - europepmc.org
Background The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is
complicated by the variable clinical course. We examined the variability in the rate of …
complicated by the variable clinical course. We examined the variability in the rate of …